Business, energy, technology, markets and global industry news from Business News Today

oncology drugs

Pharma & Biotech

What the Nexus Pharmaceuticals cyclophosphamide launch reveals about competition in sterile generic oncology drugs

Nexus Pharmaceuticals has launched cyclophosphamide injection in ready-to-dilute vials. Read what this means for oncology workflows and generic drug access.

Read More
Pharma & Biotech

Junshi Biosciences pushes subcutaneous PD-1 therapy as China’s oncology system strains

NMPA reviews subcutaneous toripalimab across 12 cancers. Discover how the delivery shift could reshape China’s immunotherapy infrastructure.

Read More
Pharma & Biotech

How Brazil’s GMP approval for pembrolizumab biosimilar changes global biosimilar dynamics

Blau Farmacêutica’s pembrolizumab biosimilar earns ANVISA GMP approval—see what this means for Brazil’s global position in cancer immunotherapy.

Read More